Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
63.10
+1.13 (1.82%)
Dec 31, 2024, 4:00 PM EST - Market closed
Belite Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Belite Bio stock have an average target of 89, with a low estimate of 57 and a high estimate of 110. The average target predicts an increase of 41.05% from the current stock price of 63.10.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
The average analyst rating for Belite Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $60 → $110 | Strong Buy | Maintains | $60 → $110 | +74.33% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $100 | Strong Buy | Maintains | $60 → $100 | +58.48% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | -4.91% | Sep 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $59 → $60 | Strong Buy | Maintains | $59 → $60 | -4.91% | Aug 13, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | -9.67% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
10.20M
EPS This Year
-1.23
from -1.19
EPS Next Year
-1.04
from -1.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 52.5M | 91.2M | |||
| Avg | n/a | 10.2M | 38.0M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 794.6% | |||
| Avg | - | - | 273.0% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.21 | 0.11 | 0.13 | |||
| Avg | -1.23 | -1.04 | -0.62 | |||
| Low | -1.24 | -1.49 | -1.56 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.